A meeting for scientists studying microbial infections in the Mid-Atlantic region
Mid-Atlantic Microbial Pathogenesis Meeting
The Mid-Atlantic Microbial Pathogenesis Meeting is a friendly gathering happening in February 2025 where students and early-career researchers can share their work on germs that cause diseases, learn from experts, and connect with others in their field.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisville NIH-funded |
| Lab location | 1 site (Louisville, United States) |
| Project ID | NIH-11074231 on NIH RePORTER |
What this research studies
The Mid-Atlantic Microbial Pathogenesis Meeting (MAMPM) is a biennial conference aimed at fostering collaboration among researchers focused on microbial pathogenesis. Scheduled for early February 2025, this event will take place at Wintergreen Resort and Conference Center in Virginia. It provides a platform for students, postdoctoral fellows, and junior faculty to present their research in a supportive environment, enhancing their professional development. The meeting will feature keynote speakers and scientific sessions that encourage networking and knowledge sharing among attendees from various states.
Who could benefit from this research
Good fit: Ideal candidates for participation would be early-career scientists and researchers in the field of microbial pathogenesis.
Not a fit: Patients who are not involved in scientific research or do not have a background in microbial pathogenesis may not benefit from this meeting.
Why it matters
Potential benefit: If successful, this meeting could enhance the collaboration and communication among researchers, leading to advancements in understanding and treating microbial infections.
How similar studies have performed: Previous meetings have successfully fostered collaboration and communication among scientists, indicating a positive track record for this type of event.
Where this research is happening
Louisville, United States
- University of Louisville — Louisville, United States (Active)
Researchers
- Principal investigator: Lawrenz, Matthew B — University of Louisville
- Study coordinator: Lawrenz, Matthew B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.